I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.36 USD -6.21% Market Closed
Market Cap: 62m USD

Wall Street
Price Targets

INCR Price Targets Summary
InterCure Ltd

There are no price targets for INCR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
InterCure Ltd Competitors:
Price Targets
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
34% Upside
ELAN
Elanco Animal Health Inc
17% Upside
200670
Humedix Co Ltd
67% Upside
ABBOTINDIA
Abbott India Ltd
31% Upside
ACUTAAS
Acutaas Chemicals Ltd
13% Upside
300363
Porton Pharma Solutions Ltd
29% Upside
600285
Henan Lingrui Pharmaceutical Co Ltd
32% Upside
XERS
Xeris Biopharma Holdings Inc
55% Upside

Revenue
Forecast

Revenue Estimate
InterCure Ltd

For the last 13 years the compound annual growth rate for InterCure Ltd's revenue is 26%. The projected CAGR for the next 2 years is 55%.

26%
Past Growth
55%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
InterCure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InterCure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
71%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INCR's stock price target?
Not Available

INCR doesn't have any price targets made by Wall Street professionals.

What is InterCure Ltd's Revenue forecast?
Projected CAGR
55%

For the last 13 years the compound annual growth rate for InterCure Ltd's revenue is 26%. The projected CAGR for the next 2 years is 55%.

Back to Top